Contrast Enhanced MRI of the CNS - Patients With Known Cerebral Neoplastic Lesions.

Clinical trial NCT00764387 · COMPLETED

Trial details

NCT number: NCT00764387
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Neoplastic CNS Lesions

Start date: 2008-03-01
Primary completion: 2009-05-01
Enrollment: 166

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.